New hope for endometriosis sufferers: Real-World pill study launches
NCT ID NCT07440043
First seen Mar 10, 2026 · Last updated May 20, 2026 · Updated 10 times
Summary
This study looks at how well a daily pill called relugolix combination therapy works for reducing endometriosis-related pain over 24 weeks in everyday medical practice. About 33 women aged 18-50 with confirmed endometriosis and moderate to severe pain will take part. The goal is to see if this treatment can ease pelvic pain and other symptoms like pain during sex or bowel movements.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.